FSOAX | JVMCX | FSOAX / JVMCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 13 years | - |
Gain YTD | 10.592 | 11.343 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.31B | 23.5B | 10% |
Annual Yield % from dividends | 0.54 | 0.01 | 3,792% |
Returns for 1 year | 25.40 | 22.57 | 113% |
Returns for 3 years | 17.48 | 8.07 | 217% |
Returns for 5 years | 66.15 | 43.82 | 151% |
Returns for 10 years | 35.61 | 57.39 | 62% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYLVX | 103.19 | 1.33 | +1.31% |
Rydex S&P 500 Pure Value A | |||
WSTCX | 31.13 | 0.40 | +1.30% |
Delaware Ivy Science and Technology C | |||
MUSBX | 36.02 | 0.34 | +0.95% |
MFS Blended Research Core Equity B | |||
AFGPX | 17.82 | 0.15 | +0.85% |
Alger International Opportunities B | |||
NUEIX | 20.84 | 0.16 | +0.77% |
Northern US Quality ESG I |